This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Arizona. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Fayez K. Ghishan: Innovator in Targeted Drug Delivery
Introduction
Fayez K. Ghishan is a prominent inventor based in Tucson, Arizona. He is known for his significant contributions to the field of targeted drug delivery, particularly in the gastrointestinal tract. His innovative approach aims to enhance the efficacy of drug administration while minimizing side effects.
Latest Patents
Fayez K. Ghishan holds a patent for a method and compositions for targeted drug delivery to the lower GI tract. This patent describes a composition and method that utilizes a base or scaffold carrier to which a drug or prodrug is fixed or covalently attached. When taken orally, the compound travels through the gastrointestinal tract, reaching the lower GI where bacterial azo reductase enzymes cleave the bonds. This process releases the drug or prodrug from the base or scaffold carrier, allowing for targeted delivery to specific cell types in the GI tract. The base or scaffold remains as a by-product and is excreted in the feces.
Career Highlights
Fayez K. Ghishan has made significant strides in his career, focusing on innovative solutions in drug delivery systems. His work has been instrumental in advancing the understanding of how to effectively deliver medications to the lower gastrointestinal tract.
Collaborations
Fayez has collaborated with notable colleagues, including Eugene A. Mash and Pawel R. Kiela, to further enhance his research and development efforts in the field of targeted drug delivery.
Conclusion
Fayez K. Ghishan's contributions to the field of targeted drug delivery exemplify the importance of innovation in medicine. His patented methods and compositions represent a significant advancement in how drugs can be effectively delivered to patients, improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile